Senior insider sale
Chief Scientific Officer at EDGEWISE THERAPEUTICS, INC. — senior position signals high conviction
$1.49M
101.91K shares
What this filing means
RUSSELL ALAN J plans to sell 101.91K shares of EDGEWISE THERAPEUTICS, INC. valued at approximately $1.49M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/26/2025ACC: 0001950047-25-006390
DirectorOfficer· Chief Scientific Officer
Since Mar 2021
101.91K
Shares to sell
$1.49M
Approx. market value
100K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
8/26/2025
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/26/2025 | Exercise of options under a registered plan Cash | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.91K
Market value
$25.5K
8/12/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
100K
Market value
$1.46M
8/26/2025
Total
Units
101.91K
Value
$1.49M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/12/2025 | 1.91K | $25.5K | — | Completed |
| Planned — Approximate Date | ||||
8/26/2025 | 100K | $1.46M | NASDAQ | Planned |
| Total | 101.91K | $1.49M | ||